Aptar Pharma has announced that the Chinese State Food and Drug Administration (SFDA) has issued the company an import license for its preservative-free multi-dose opthalmic and nasal devices in accordance with regulations that require “Examination and approval for packaging materials and containers in direct contact with drugs” prior to marketing. Aptar’s APF (advanced preservative free) nasal spray pumps utilize a spring-loaded tip seal to prevent contamination.
The company has had a presence in China since 1996 and manufactures pMDI metering valves and spray pumps for the Chinese market at its facility in Suzhou.
Aptar Pharma CHC Division VP of Business Development Matthias Birkhoff commented, “We are pleased to announce the import license for the OSD technology and APF pump technology to China. We have had tremendous success marketing these technologies in other regions of the world and we are confident that our customers and consumers in China will value the benefits of our preservative free systems. As with any of our technologies, we continue to invest in ways to even further improve our devices as we adapt to our customers’ future needs and expectations.”
Read the Aptar Pharma press release.
